4
Changes in Ownership
BOSTON SCIENTIFIC CORP Filed Acc 0001225208-22-002675
EVP Global Chief Med Officer gave up 326 shares (to pay taxes)
- EVP Global Chief Med Officer acquired 1,108 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Meredith Ian T · EVP Global Chief Med Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-02-15 | Exercise or conversion : show line 1 in the form | +1,108 | 31,947 | D | ||
| 2022-02-15 | Shares withheld for taxes : show line 2 in the form | −326 | $44.01 | $14,347 | 31,621 | D |
Table II: Derivative
3 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2022-02-15 | Exercise or conversion : show line 3 in the form Deferred Stock Units | −1,108 | 2023-02-15 | 1,108 | 1,108 | D | |
| 2022-02-16 | Grant or award : show line 4 in the form Restricted Stock Units | +4,525 | 2026-02-16 | 4,525 | 4,525 | D | |
| 2022-02-16 | Grant or award : show line 5 in the form Stock Option (Right to Buy) | +12,941 | $44.19 | 2032-02-16 | 12,941 | 12,941 | D |
Loading xslF345X03/doc4.xml…